Agentix (AGTX) Amortizatization of Intangibles (2016 - 2019)
Agentix's (AGTX) quarterly Amortizatization of Intangibles came in at $329.0 in Q4 2019, down 66.46% YoY from $981.0 in Q4 2018, and down 66.46% on a QoQ basis from $981.0 in Q3 2019.
Agentix (AGTX) Amortizatization of Intangibles (2016 - 2019) Analysis & Trends
Agentix (AGTX) has 4 years of Amortizatization of Intangibles data on file, last reported at $329.0 in Q4 2019.
- Quarterly Amortizatization of Intangibles fell 66.46% year-over-year to $329.0 in Q4 2019, while the trailing twelve-month figure through Feb 2020 was $2291.0 (down 74.11% YoY) and the FY2019 annual result came in at $3924.0, down 77.34% from the prior year.
- Amortizatization of Intangibles fell to $329.0 in Q4 2019, from $981.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $5906.0 in Q2 2018 to a low of -$14025.0 in Q3 2017.
- A 4-year average of $524.62 and a median of $981.0 in 2018 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2018 — Amortizatization of Intangibles surged 20265.52% — and 2019, when it slumped 83.39%.
- Tracing AGTX's Amortizatization of Intangibles over 4 years: stood at $1811.0 in 2016, then soared by 187.96% to $5215.0 in 2017, then slumped by 81.19% to $981.0 in 2018, then tumbled by 66.46% to $329.0 in 2019.
- The last three Amortizatization of Intangibles figures came in at $329.0 (Q4 2019), $981.0 (Q3 2019), and $981.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2019 | 329.00 |
| Nov 30, 2019 | 329.00 |
| Aug 31, 2019 | 981.00 |
| Aug 31, 2019 | 981.00 |
| May 31, 2019 | 981.00 |
| May 31, 2019 | 981.00 |
| Feb 28, 2019 | 981.00 |
| Feb 28, 2019 | 981.00 |
| Nov 30, 2018 | 981.00 |
| Nov 30, 2018 | 981.00 |
| Aug 31, 2018 | 981.00 |
| Aug 31, 2018 | 981.00 |
| May 31, 2018 | 5,906.00 |
| May 31, 2018 | 5,906.00 |
| Feb 28, 2018 | 5,215.00 |
| Feb 28, 2018 | 5,215.00 |
| Nov 30, 2017 | 5,215.00 |
| Nov 30, 2017 | 5,215.00 |
| Aug 31, 2017 | -14,025.00 |
| Aug 31, 2017 | -14,025.00 |